Bacteraemia and antibiotic-resistant pathogens in community acquired pneumonia: Risk and prognosis

European Respiratory Journal

Volumn 45, Issue 5, 2015, Pages 1353-1363

  Torres, Antoni ^a   Cillóniz, Catia ^a   Ferrer, Miquel ^a   Gabarrús, Albert ^a   Polverino, Eva ^a   Villegas, Santiago ^b   Marco, Francesc ^c   Mensa, Josep ^c   Menéndez, Rosario ^d   Niederman, Michael ^e  

^a UNIVERSITY OF BARCELONA   (Spain)

^b UNIVERSIDAD CES   (Colombia)

^c HOSPITAL CLÍNIC   (Spain)

^d HOSPITAL UNIVERSITARIO LA FE   (Spain)

^e WINTHROP UNIVERSITY HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; C REACTIVE PROTEIN; PNEUMOCOCCUS VACCINE; ANTIINFECTIVE AGENT;

ADULT; ANTIBIOTIC RESISTANCE; ANTIBIOTIC RESISTANT PATHOGEN; ARTERIAL OXYGEN TENSION; ARTICLE; BACTEREMIA; COMMUNITY ACQUIRED PNEUMONIA; CONTROLLED STUDY; DISEASE SEVERITY; ESCHERICHIA COLI; EXTENDED SPECTRUM BETA LACTAMASE PRODUCING ENTEROBACTERIACEAE; FEMALE; HAEMOPHILUS INFLUENZAE; HUMAN; INFECTION RISK; INTENSIVE CARE UNIT; MALE; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MORTALITY; MULTIDRUG RESISTANT STREPTOCOCCUS PNEUMONIAE; NEUROLOGIC DISEASE; NONHUMAN; OBSERVATIONAL STUDY; PLEURISY; PRIORITY JOURNAL; PROGNOSIS; PROSPECTIVE STUDY; PSEUDOMONAS AERUGINOSA; RISK ASSESSMENT; STREPTOCOCCUS PNEUMONIAE; AGED; CHEMISTRY; COMMUNITY ACQUIRED INFECTION; COMPLICATION; ENTEROBACTERIACEAE; METABOLISM; MIDDLE AGED; MULTIVARIATE ANALYSIS; PNEUMONIA; RECEIVER OPERATING CHARACTERISTIC; RISK FACTOR; SPAIN; TREATMENT OUTCOME;

ADULT; AGED; ANTI-BACTERIAL AGENTS; BACTEREMIA; C-REACTIVE PROTEIN; COMMUNITY-ACQUIRED INFECTIONS; DRUG RESISTANCE, BACTERIAL; ENTEROBACTERIACEAE; FEMALE; HUMANS; MALE; METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS; MIDDLE AGED; MULTIVARIATE ANALYSIS; PNEUMONIA; PROSPECTIVE STUDIES; PSEUDOMONAS AERUGINOSA; RISK FACTORS; ROC CURVE; SPAIN; STREPTOCOCCUS PNEUMONIAE; TREATMENT OUTCOME;

EID: 84929001391     PISSN: 09031936     EISSN: 13993003     Source Type: Journal    
DOI: 10.1183/09031936.00152514     Document Type: Article

References (20)

1. Ewig S, Torres A. Community-acquired pneumonia as an emergency: Time for an aggressive intervention to lower mortality. Eur Respir J 2011; 38: 253-260.
2. Niederman MS, Mandell LA, Anzueto A, et al. Guidelines for the management of adults with communityacquired pneumonia: Diagnosis, assessment of severity, antimicrobial therapy, and prevention. Am J Respir Crit Care Med 2001; 163: 1730-1754.
3. Lin SH, Lai CC, Tan CK, et al. Outcomes of hospitalized patients with bacteraemic and non-bacteraemic community-acquired pneumonia caused by Streptococcus pneumoniae. Epidemiol Infect 2011; 139: 1307-1316.
4. Bordon J, Peyrani P, Brock GN, et al. The presence of pneumococcal bacteremia does not influence clinical outcomes in patients with community-acquired pneumonia: results from the Community-Acquired Pneumonia Organization (CAPO) International Cohort study. Chest 2008; 133: 618-624.
5. Garnacho-Montero J, Garcia-Cabrera E, Diaz-Martin A, et al. Determinants of outcome in patients with bacteraemic pneumococcal pneumonia: Importance of early adequate treatment. Scand J Infect Dis 2010; 42: 185-192.
6. Mandell LA, Wunderink RG, Anzueto A, et al. Infectious Diseases Society of America/American Thoracic Society consensus guidelines on the management of community-acquired pneumonia in adults. Clin Infect Dis 2007; 44: Suppl. 2, S27-S72.
7. Woodhead M, Blasi F, Ewig S, et al. Guidelines for the management of adult lower respiratory tract infections-full version. Clin Microbiol Infect 2011; 17; Suppl. 6, E1-E59.
8. Metersky ML, Ma A, Bratzler DW, et al. Predicting bacteremia in patients with community-acquired pneumonia. Am J Respir Crit Care Med 2004; 169: 342-347.
9. Falguera M, Trujillano J, Caro S, et al. A prediction rule for estimating the risk of bacteremia in patients with community-acquired pneumonia. Clin Infect Dis 2009; 49: 409-416.
10. Fine MJ, Auble TE, Yealy DM, et al. A prediction rule to identify low-risk patients with community-acquired pneumonia. N Engl J Med 1997; 336: 243-250.
11. Lim WS, van der Eerden MM, Laing R, et al. Defining community acquired pneumonia severity on presentation to hospital: An international derivation and validation study. Thorax 2003; 58: 377-382.
12. Rice LB. Federal funding for the study of antimicrobial resistance in nosocomial pathogens: no ESKAPE. J Infect Dis 2008; 197: 1079-1081.
13. Torres A, Barberan J, Falguera M, et al. Guia multidisciplinar para la valoracion pronóstica, diagnostico y Tratamiento de la neumonia adquirida en la comunidad [Multidisciplinary guidelines for the management of community-acquired pneumonia]. Med Clin (Barc) 2013; 140: 223.e1-223.e19.
14. Hosmer D, Lemeshow S. Applied logistic regression. New York, John Wiley & Sons Inc., 1989.
15. Waterer GW, Wunderink RG. The influence of the severity of community-acquired pneumonia on the usefulness of blood cultures. Respir Med 2001; 95: 78-82.
16. Riedel S, Bourbeau P, Swartz B, et al. Timing of specimen collection for blood cultures from febrile patients with bacteremia. J Clin Microbiol 2008; 46: 1381-1385.
17. Mylotte JM, Tayara A. Blood cultures: Clinical aspects and controversies. Eur J Clin Microbiol Infect Dis 2000; 19: 157-163.
18. Shorr AF, Zilberberg MD, Reichley R, et al. Validation of a clinical score for assessing the risk of resistant pathogens in patients with pneumonia presenting to the emergency department. Clin Infect Dis 2012; 54: 193-198.
19. Aliberti S, Di Pasquale M, Zanaboni AM, et al. Stratifying risk factors for multidrug-resistant pathogens in hospitalized patients coming from the community with pneumonia. Clin Infect Dis 2012; 54: 470-478.
20. Aliberti S, Cilloniz C, Chalmers JD, et al. Multidrug-resistant pathogens in hospitalised patients coming from the community with pneumonia: A European perspective. Thorax 2013; 68: 997-999.